Twelve-year results of LINAC-based radiosurgery for vestibular schwannomas.

Zwölfjahresergebnisse der LINAC-basierten Radiochirurgie für Vestibularisschwannome.

Journal

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]
ISSN: 1439-099X
Titre abrégé: Strahlenther Onkol
Pays: Germany
ID NLM: 8603469

Informations de publication

Date de publication:
Jan 2020
Historique:
received: 07 12 2018
accepted: 10 07 2019
pubmed: 7 8 2019
medline: 13 6 2020
entrez: 7 8 2019
Statut: ppublish

Résumé

To report long-term outcomes of 53 patients with vestibular schwannomas (VS) submitted to a single high-dose LINAC-based radiosurgery (SRS) in our institution. 48 (92%) patients were evaluable for clinical and MRI response as well as late toxicity. At a median follow-up of 12 years (range 2-16 years), local control (LC), hearing capacity, trigeminal and facial nerve function, and toxicity were assessed. Hearing capacity was classified according to the Gardner-Robertson scale, where class I-II patients had "serviceable hearing." Median dose of SRS was 16.5 Gy (range 13-20 Gy) and median tumor volume 1.7 cm LC and hearing preservation after SRS were excellent. Toxicity proved acceptable. Although the median administered dose (16.5 Gy) was rather high, the only factor which significantly influenced late toxicity was Koos tumor grade III-IV.

Identifiants

pubmed: 31384957
doi: 10.1007/s00066-019-01498-7
pii: 10.1007/s00066-019-01498-7
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

40-47

Références

J Am Geriatr Soc. 1998 Sep;46(9):1069-74
pubmed: 9736097
J Neurosurg. 2014 Dec;121 Suppl:123-42
pubmed: 25434946
N Engl J Med. 1998 Nov 12;339(20):1426-33
pubmed: 9811917
Radiother Oncol. 2013 Feb;106(2):169-74
pubmed: 23219253
Otol Neurotol. 2012 Aug;33(6):1053-8
pubmed: 22710554
Radiother Oncol. 2011 Dec;101(3):420-4
pubmed: 21741718
J Neurosurg. 2009 Oct;111(4):855-62
pubmed: 19301957
J Neurosurg. 2010 Dec;113 Suppl:105-11
pubmed: 21121792
Int J Radiat Oncol Biol Phys. 2003 Aug 1;56(5):1390-6
pubmed: 12873685
Int J Radiat Oncol Biol Phys. 2011 Jul 15;80(4):1143-50
pubmed: 20675080
Acta Otorhinolaryngol Ital. 2011 Apr;31(2):76-84
pubmed: 22064847
World Neurosurg. 2018 Jun;114:e1192-e1198
pubmed: 29614352
J Neurosurg. 2016 Dec;125(Suppl 1):64-72
pubmed: 27903183
Rep Pract Oncol Radiother. 2016 Jul-Aug;21(4):399-406
pubmed: 27330427
Int J Radiat Oncol Biol Phys. 2002 Oct 1;54(2):311-2
pubmed: 12243801
Otol Neurotol. 2011 Jun;32(4):676-9
pubmed: 21436750
J Neurosurg. 2018 Mar 2;:1-10
pubmed: 29498575
Arch Otolaryngol Head Neck Surg. 2003 Aug;129(8):903-6
pubmed: 12925354
Otol Neurotol. 2006 Aug;27(5):705-12
pubmed: 16868519
Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):e503-9
pubmed: 21665381
Neurosurg Rev. 2011 Jul;34(3):265-77; discussion 277-9
pubmed: 21305333
Int J Radiat Oncol Biol Phys. 2011 Nov 1;81(3):647-53
pubmed: 20884130
Otolaryngol Clin North Am. 2012 Apr;45(2):269-84, vii
pubmed: 22483815
Radiother Oncol. 2015 Mar;114(3):378-83
pubmed: 25702864
Curr Opin Otolaryngol Head Neck Surg. 2012 Oct;20(5):367-71
pubmed: 22931906
Radiother Oncol. 2013 Feb;106(2):175-80
pubmed: 23333012
Int J Radiat Oncol Biol Phys. 2001 Aug 1;50(5):1265-78
pubmed: 11483338
Radiat Oncol. 2017 Apr 21;12(1):68
pubmed: 28427410
J Neurosurg. 2013 Mar;118(3):557-65
pubmed: 23140152
Otol Neurotol. 2012 Feb;33(2):230-8
pubmed: 22222572
Otol Neurotol. 2012 Dec;33(9):1611-20
pubmed: 22996165
Int J Radiat Oncol Biol Phys. 2006 Apr 1;64(5):1341-7
pubmed: 16464537
Neurol Res. 2003 Oct;25(7):682-90
pubmed: 14579782
Int J Radiat Oncol Biol Phys. 2000 Dec 1;48(5):1381-7
pubmed: 11121637
World Neurosurg. 2018 Aug;116:e194-e202
pubmed: 29715569
Laryngoscope. 2005 Mar;115(3):450-4
pubmed: 15744156
Clin Otolaryngol. 2014 Feb;39(1):22-31
pubmed: 24313969
Int J Radiat Oncol Biol Phys. 2011 Aug 1;80(5):1485-91
pubmed: 20708852
Gerontology. 1999 Nov-Dec;45(6):323-8
pubmed: 10559650

Auteurs

Paola Anselmo (P)

Radiotherapy Oncology Centre, "S. Maria" Hospital, Via T. di Joannuccio, 1, 05100, Terni, Italy.

Michelina Casale (M)

Radiotherapy Oncology Centre, "S. Maria" Hospital, Via T. di Joannuccio, 1, 05100, Terni, Italy.

Fabio Arcidiacono (F)

Radiotherapy Oncology Centre, "S. Maria" Hospital, Via T. di Joannuccio, 1, 05100, Terni, Italy.

Fabio Trippa (F)

Radiotherapy Oncology Centre, "S. Maria" Hospital, Via T. di Joannuccio, 1, 05100, Terni, Italy.

Rossella Rispoli (R)

Neurosurgery Division, "S. Maria" Hospital, Via T. di Joannuccio, 1, 05100, Terni, Italy.

Lorena Draghini (L)

Radiotherapy Oncology Centre, "S. Maria" Hospital, Via T. di Joannuccio, 1, 05100, Terni, Italy.

Sara Terenzi (S)

Radiotherapy Oncology Centre, "S. Maria" Hospital, Via T. di Joannuccio, 1, 05100, Terni, Italy.

Alessandro Di Marzo (A)

Radiotherapy Oncology Centre, "S. Maria" Hospital, Via T. di Joannuccio, 1, 05100, Terni, Italy.

Ernesto Maranzano (E)

Radiotherapy Oncology Centre, "S. Maria" Hospital, Via T. di Joannuccio, 1, 05100, Terni, Italy. e.maranzano@aospterni.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH